Revenue: The sum of all revenue fields included for a company's operating activities.
Entero Therapeutics, Inc. (ENTO) Revenue data is not available.
| Income Statement Financials | |
|
Revenue |
-- |
$-18.30M |
|
-- |
|
-- |
|
$15.62M |
|
$-15.62M |
|
$0.00M |
|
$-15.62M |
|
$-15.62M |
|
$-15.62M |
|
$-15.62M |
|
$-18.06M |
|
$-15.62M |
|
$-15.62M |
|
$-15.57M |
|
3.43M |
|
3.43M |
|
$-5.33 |
|
$-5.33 |
|
| Balance Sheet Financials | |
$83.48M |
|
-- |
|
$1.93M |
|
$85.41M |
|
$27.55M |
|
-- |
|
$0.06M |
|
$27.61M |
|
$-3.88M |
|
$56.12M |
|
$57.80M |
|
4.75M |
|
| Cash Flow Statement Financials | |
$-9.22M |
|
$0.09M |
|
$5.58M |
|
$3.73M |
|
$0.18M |
|
$-3.55M |
|
$2.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
402.89% |
|
-27.83% |
|
-18.29% |
|
-27.02% |
|
$12.16 |
|
$-2.68 |
|
$-2.68 |
|